INS and metabolic dysfunction-associated steatotic liver disease: Since glucose metabolism is another important assessment indicator in NAFLD, the oral glucose tolerance test (OGTT), HOMA-IR, and the insulin tolerance test (ITT) were measured on the sixth, seventh, and eighth week.